Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Sage Journals HomeSage Journals Home
loading
Corrigendum to “Outcomes of patients with refractory upper GI cancers enrolled in phase I trials: a 10-year analysis from the Sarah Cannon Research Institute UK Drug Development Unit”